Pregnancy Clinical Trial
Official title:
Libera Efficacy 2 Cycles at Home Study
Verified date | July 2018 |
Source | SPD Development Company Limited |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Clearblue Connected Ovulation Test System (COTS) has been designed for home use by women who are either planning or trying for a pregnancy. This study will determine the difference in pregnancy rate of female volunteers seeking to get pregnant who use COTS in comparison to those not using an ovulation product to assist with conception.
Status | Completed |
Enrollment | 1000 |
Est. completion date | September 19, 2018 |
Est. primary completion date | September 19, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Actively trying to conceive - At least 2 regular consecutive cycles since last pregnancy/ miscarriage/ or since stopping breastfeeding - Willing to use their own smartphone for the duration of this study and to download and install the study app - Willing to disclose their pregnancy status and provide urine samples to test markers related to pregnancy and fertility - Have internet access on their phone for the duration of the study - Willing to give informed consent and comply with the investigational procedures Exclusion Criteria: - Currently or previously employed by SPD, Alere, Abbott, Unipath or P&G, or affiliates - Has an immediate relative* currently or previously employed by SPD, Alere, Abbott, Unipath or P&G or affiliates - There is a reason why the volunteer should not get pregnant e.g. they are taking a medication or have a medical condition which means they should not get pregnant - Trying to conceive for more than 6 months (if less than 35 years old) and more than 3 months (if 35 years old or over) - Has been diagnosed with Polycystic Ovarian Syndrome (PCOS) - Has PCOS symptoms: very irregular cycles, hirsutism - Using or has previously used infertility medications or hormone replacement therapy containing hCG or LH (e.g Pregnyl) - Are taking clomiphene citrate or other ovulation induction drugs - Using any treatment which may affect the menstrual cycle (e.g. the contraceptive pill) - Currently pregnant or breastfeeding - Peri- or post-menopausal, e.g. experiencing symptoms: Irregular menstrual periods, hot flushes, night sweats, sleep disturbances, and mood swings - Have abnormal liver or kidney function - Taking medication containing tetracycline - Using or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as IVF or ICSI - Has a phone that is known to be incompatible with COTS |
Country | Name | City | State |
---|---|---|---|
United Kingdom | SPD Development Company Ltd | Bedford | Bedfordshire |
Lead Sponsor | Collaborator |
---|---|
SPD Development Company Limited |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in pregnancy rates across 2 cycles of use between volunteers trying to conceive in the home setting using (i) COTS, (ii) no intervention. | The difference in pregnancy rates between volunteers trying to conceive in the home setting using (i) COTS (ii) no intervention | 2 months | |
Secondary | Assessment of behaviour of women trying to conceive | Quantitative assessment in methods used to try and help with conception and intercourse patterns. | 2 months | |
Secondary | Evaluation of women's experience of trying to conceive using COTS compared to not using ovulation tests | Qualitative interview responses regarding usage and experience of COTS or other methods whilst trying to conceive. | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |